US101A
(en)
|
|
1836-12-06 |
|
Method of jcakibtg and furling iw sails fob ships |
US5530A
(en)
|
|
1848-04-25 |
|
Horse-power |
US5208036A
(en)
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2, Inc., Danville, Calif. |
Geänderte antikörper.
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
EP0940468A1
(en)
|
1991-06-14 |
1999-09-08 |
Genentech, Inc. |
Humanized antibody variable domain
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
ES2322324T3
(es)
|
1992-08-21 |
2009-06-19 |
Vrije Universiteit Brussel |
Inmumoglobulinas desprovistas de cadenas ligeras.
|
AU6014094A
(en)
|
1992-12-02 |
1994-06-22 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
US5843779A
(en)
|
1992-12-14 |
1998-12-01 |
N.V. Innogenetics S.A. |
Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies
|
ES2318848T3
(es)
|
1993-09-14 |
2009-05-01 |
Pharmexa Inc. |
Peptidos que se unen a pan dr para potenciar la respuesta inmunitaria.
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
DE19539493A1
(de)
|
1995-10-24 |
1997-04-30 |
Thomae Gmbh Dr K |
Starker homologer Promotor aus Hamster
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
PT1005368E
(pt)
|
1997-03-10 |
2009-11-19 |
Coley Pharm Gmbh |
Utilização de ácidos nucleicos contendo dinucleótidos cpg não metilados em combinação com alúmen como adjuvante
|
US5888809A
(en)
|
1997-05-01 |
1999-03-30 |
Icos Corporation |
Hamster EF-1α transcriptional regulatory DNA
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
DE60045319D1
(de)
|
1999-02-05 |
2011-01-13 |
Samsung Electronics Co Ltd |
Verfahren und Vorrichtung zum Wiederauffinden von Texturbildern
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
EP1535930B1
(en)
|
2002-08-14 |
2010-10-06 |
Mitsubishi Chemical Medience Corporation |
Antibody specific to central nervous system tau protein
|
WO2008103472A2
(en)
|
2007-02-23 |
2008-08-28 |
Elan Pharmaceuticals, Inc. |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
WO2004050884A2
(de)
|
2002-11-29 |
2004-06-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue neomycin-phosphotransferase-gene und verfahren zur selektion von hochproduzierenden rekombinanten zellen
|
US7847146B2
(en)
|
2003-03-28 |
2010-12-07 |
Baylor College Of Medicine |
Model for neurodegenerative disorders
|
DE10338531A1
(de)
|
2003-08-19 |
2005-04-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Reklonierung von Produktionszellen
|
US20050132424A1
(en)
|
2003-10-21 |
2005-06-16 |
Envivo Pharmaceuticals, Inc. |
Transgenic flies expressing Abeta42-Dutch
|
JP2008520186A
(ja)
|
2004-10-01 |
2008-06-19 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
哺乳類eag1イオンチャネルタンパク質に対する新規の抗体
|
ES2325931T3
(es)
|
2004-11-10 |
2009-09-24 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Utilizacion del analisis por citometria de flujo para optimizar las estrategias de almacenamiento en bancos de celulas para celulas cho.
|
AU2005318171B2
(en)
|
2004-12-20 |
2011-09-29 |
Crucell Holland B.V. |
Binding molecules capable of neutralizing West Nile virus and uses thereof
|
CA2593693A1
(en)
|
2004-12-30 |
2006-07-13 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Framework residue substituted humanized col-1 antibodies and their use
|
US8012936B2
(en)
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
EP2028932A4
(en)
|
2006-06-16 |
2011-10-12 |
Vitruvean Llc |
TAU AND AMYLOID FOREIGNER FRAGMENT EXPRESSING TRANSGENIC FLY
|
US8301398B2
(en)
|
2006-06-22 |
2012-10-30 |
Walter And Eliza Hall Institute Of Medical Research |
Structure of the insulin receptor ectodomain
|
US20080124760A1
(en)
|
2006-07-26 |
2008-05-29 |
Barbara Enenkel |
Regulatory Nucleic Acid Elements
|
US20100216703A1
(en)
|
2006-08-14 |
2010-08-26 |
The Regents Of The University Of California |
Inhibitors of PDE4 and Methods of Use
|
TWI447124B
(zh)
|
2006-12-01 |
2014-08-01 |
Medarex Llc |
結合cd22的人類抗體與其應用
|
EP2522729A1
(en)
|
2007-03-02 |
2012-11-14 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Improvement of protein production
|
EP2031064A1
(de)
|
2007-08-29 |
2009-03-04 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verfahren zur Steigerung von Proteintitern
|
JP2009056790A
(ja)
|
2007-09-03 |
2009-03-19 |
Takao Otogawa |
ファイル用ポケット
|
SI2207809T1
(sl)
|
2007-09-26 |
2013-11-29 |
U3 Pharma Gmbh |
Proteini, ki veĹľejo antigen rastnega faktorja, podobnega epidermalnemu rastnemu faktorju, ki veĹľe heparin
|
US9272030B2
(en)
|
2007-10-17 |
2016-03-01 |
Janssen Sciences Ireland Uc |
Use of tau to monitor immunotherapy
|
CN101903402B
(zh)
|
2007-11-13 |
2014-07-16 |
泰华生物制药美国公司 |
抗tl1a的人源化抗体
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
JP2010014691A
(ja)
|
2008-06-20 |
2010-01-21 |
Igaku Seibutsugaku Kenkyusho:Kk |
腹水中のメソテリン及び/又は巨核球増強因子を検出するための方法、キット、試薬及び装置
|
JP5685535B2
(ja)
|
2008-08-18 |
2015-03-18 |
ファイザー インコーポレイティッド |
Ccr2に対する抗体
|
US9605054B2
(en)
|
2009-02-23 |
2017-03-28 |
The Board Of Trustees Of The University Of Illinois |
Composition and method for treating a tauopathy
|
SG176060A1
(en)
|
2009-05-13 |
2011-12-29 |
Genzyme Corp |
Anti-human cd52 immunoglobulins
|
WO2010144711A2
(en)
|
2009-06-10 |
2010-12-16 |
New York University |
Immunological targeting of pathological tau proteins
|
US20110045534A1
(en)
|
2009-08-20 |
2011-02-24 |
Cell Signaling Technology, Inc. |
Nucleic Acid Cassette For Producing Recombinant Antibodies
|
JP6124591B2
(ja)
|
2009-08-28 |
2017-05-10 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
タウオリゴマーに結合する抗体
|
WO2011053565A2
(en)
|
2009-10-29 |
2011-05-05 |
Biomedical Sciences Research Centre "Alexander Fleming" |
Compositions and methods for detecting a tauopathy
|
AU2010330794A1
(en)
|
2009-12-18 |
2012-06-21 |
Amgen Inc. |
Wise binding agents and epitopes
|
EP2522360B1
(en)
|
2010-01-08 |
2016-11-16 |
Kyoto University |
Vaccine for treatment of tauopathy
|
US8877897B2
(en)
|
2010-02-23 |
2014-11-04 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
JP2011201655A
(ja)
|
2010-03-25 |
2011-10-13 |
Minoru Industrial Co Ltd |
ダンボールテープ貼付機
|
ES2684475T3
(es)
|
2010-04-15 |
2018-10-03 |
Abbvie Inc. |
Proteínas que se unen a beta amiloide
|
ITRM20100320A1
(it)
|
2010-06-11 |
2011-12-11 |
Consiglio Nazionale Ricerche |
Metodo per la diagnostica e il trattamento delle taupatie
|
US20120023911A1
(en)
|
2010-07-28 |
2012-02-02 |
Gm Global Technology Operations, Inc. |
Detection of exhaust particulate filter substrate failure
|
US8940272B2
(en)
|
2010-10-11 |
2015-01-27 |
University Of Zurich |
Human anti-tau antibodies
|
US8741298B2
(en)
|
2011-02-07 |
2014-06-03 |
Neotope Biosciences Limited |
APOE immunotherapy
|
WO2012149365A2
(en)
|
2011-04-27 |
2012-11-01 |
Northwestern University |
Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
|
GB201109238D0
(en)
|
2011-06-01 |
2011-07-13 |
Antitope Ltd |
Antibodies
|
GB201111361D0
(en)
|
2011-07-04 |
2011-08-17 |
Nordic Bioscience As |
Biochemical markers for neurodegenerative conditions
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
SG11201400916XA
(en)
|
2011-08-22 |
2014-06-27 |
Cangene Corp |
Clostridium difficile antibodies
|
UA115657C2
(uk)
*
|
2011-09-19 |
2017-12-11 |
Аксон Ньюросайєнс Сє |
Виділене антитіло, яке зв'язується з одним або декількома епітопами тау, фармацевтична композиція, що його містить, спосіб лікування та спосіб діагностики хвороби альцгеймера на основі виділеного антитіла
|
TW201326209A
(zh)
|
2011-09-30 |
2013-07-01 |
Chugai Pharmaceutical Co Ltd |
具有促進抗原清除之FcRn結合域的治療性抗原結合分子
|
US9540434B2
(en)
|
2011-10-07 |
2017-01-10 |
Ac Immune S.A. |
Phosphospecific antibodies recognising tau
|
US9738709B2
(en)
|
2011-10-21 |
2017-08-22 |
Ohio State Innovation Foundation |
Methylated peptides derived from tau protein and their antibodies for diagnosis and therapy of alzheimer's disease
|
UA117097C2
(uk)
|
2012-03-28 |
2018-06-25 |
Санофі |
Антитіло проти лігандів рецептора в1 брадикініну
|
JP6293731B2
(ja)
|
2012-04-05 |
2018-03-14 |
エーシー イミューン エス.エー. |
ヒト化タウ抗体
|
BR112014025974A2
(pt)
|
2012-04-18 |
2017-06-27 |
Du Pont |
folha em camadas.
|
DE102012211455A1
(de)
|
2012-07-02 |
2014-01-02 |
Wobben Properties Gmbh |
Handhabungsvorrichtung zum Handhaben einer Rotorblattform zum Fertigen eines Rotorblattes einer Windenergieanlage
|
KR20150036346A
(ko)
|
2012-07-03 |
2015-04-07 |
워싱턴 유니버시티 |
Tau에 대한 항체
|
ME03667B
(me)
|
2012-08-16 |
2020-10-20 |
Ipierian Inc |
Metodi lečenja tauopatije
|
US20140056901A1
(en)
|
2012-08-21 |
2014-02-27 |
The Institute For Molecular Medicine |
Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
EP2906596B1
(en)
|
2012-10-12 |
2023-12-27 |
Arizona Board of Regents on behalf of Arizona State University |
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
|
US9200068B2
(en)
|
2012-12-18 |
2015-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods related to tauopathy
|
BR112015014751A8
(pt)
|
2012-12-21 |
2018-01-16 |
Biogen Int Neuroscience Gmbh |
anti-corpos anti-tau humanos e fragmento de ligação a tau dos mesmo, seu uso na preparação de um medicamento, bem como polipeptídeos codificando os mesmos.
|
US8980270B2
(en)
|
2013-01-18 |
2015-03-17 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
US9364191B2
(en)
|
2013-02-11 |
2016-06-14 |
University Of Rochester |
Method and apparatus of spectral differential phase-contrast cone-beam CT and hybrid cone-beam CT
|
SG10201707855YA
(en)
|
2013-03-13 |
2017-10-30 |
Prothena Biosciences Ltd |
Tau immunotherapy
|
AU2014240063B2
(en)
|
2013-03-15 |
2019-04-11 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
US11761959B2
(en)
|
2013-03-15 |
2023-09-19 |
The Trustees Of The University Of Pennsylvania |
Blood biomarker that predicts persistent cognitive dysfunction after concussion
|
US20150056199A1
(en)
|
2013-08-22 |
2015-02-26 |
Acceleron Pharma, Inc. |
Tgf-beta receptor type ii variants and uses thereof
|
EA038994B1
(ru)
|
2013-11-27 |
2021-11-18 |
Айпириэн, Инк. |
Способы лечения таупатии
|
WO2015089375A1
(en)
|
2013-12-13 |
2015-06-18 |
The General Hospital Corporation |
Soluble high molecular weight (hmw) tau species and applications thereof
|
KR102357961B1
(ko)
|
2013-12-17 |
2022-02-08 |
제넨테크, 인크. |
항-cd3 항체 및 이의 사용 방법
|
US9629801B2
(en)
|
2014-01-10 |
2017-04-25 |
Wisconsin Alumni Research Foundation |
Blood-brain barrier targeting antibodies
|
US20150253341A1
(en)
|
2014-02-10 |
2015-09-10 |
Merck Sharp & Dohme Corp. |
Quantification of tau in biological samples by immunoaffinity enrichment and mass spectrometry
|
WO2015197820A1
(en)
|
2014-06-26 |
2015-12-30 |
Crucell Holland B.V. |
Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
|
TWI734975B
(zh)
|
2014-06-27 |
2021-08-01 |
美商C2N醫療診斷有限責任公司 |
人類化抗-tau抗體
|
HUE053239T2
(hu)
|
2014-11-19 |
2021-06-28 |
Axon Neuroscience Se |
Humanizált tau-ellenanyagok Alzheimer-kór kezelésére
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
WO2016137950A1
(en)
|
2015-02-24 |
2016-09-01 |
Rpeptide, Llc |
Anti-tau antibodies
|
CA2986942A1
(en)
|
2015-06-05 |
2016-12-08 |
Genentech, Inc. |
Anti-tau antibodies and methods of use
|
EP3307320A4
(en)
|
2015-06-12 |
2019-03-06 |
C2N Diagnostics LLC |
Stable formulations of humanized anti-tau antibodies
|
TN2017000543A1
(en)
|
2015-07-06 |
2019-04-12 |
Ucb Biopharma Sprl |
Tau-binding antibodies
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
US11327080B2
(en)
|
2015-07-21 |
2022-05-10 |
BioArctic Neruoscience AB |
Method for treatment of traumatic brain injury targeting aggregated peptides
|
CN117069841A
(zh)
|
2015-10-06 |
2023-11-17 |
艾利妥 |
抗trem2抗体及其使用方法
|
JP7170316B2
(ja)
*
|
2016-05-02 |
2022-11-14 |
プロセナ バイオサイエンシーズ リミテッド |
タウ免疫療法
|
MY197413A
(en)
|
2016-05-02 |
2023-06-16 |
Prothena Biosciences Ltd |
Antibodies recognizing tau
|
US10889638B2
(en)
|
2016-05-02 |
2021-01-12 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
WO2018085653A1
(en)
|
2016-11-04 |
2018-05-11 |
The Regents Of The University Of California |
Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them
|
KR102645073B1
(ko)
|
2016-12-07 |
2024-03-11 |
제넨테크, 인크. |
항-타우 항체 및 이의 이용 방법
|
CA3044679A1
(en)
|
2016-12-07 |
2018-06-14 |
Genentech, Inc. |
Anti-tau antibodies and methods of use
|
MX2019009817A
(es)
|
2017-02-17 |
2019-11-21 |
Denali Therapeutics Inc |
Anticuerpos anti-tau y metodos de uso de los mismos.
|
WO2018156250A1
(en)
|
2017-02-21 |
2018-08-30 |
Remd Biotherapeutics, Inc. |
Cancer treatment using antibodies that bind cytotoxic t-lymphocyte antigen-4 (ctla-4)
|
JOP20180021A1
(ar)
|
2017-03-16 |
2019-01-30 |
Janssen Biotech Inc |
الأجسام المضادة لتكتلات خيوط بروتين تاو (tau) الحلزونية المزدوجة واستخداماتها
|
WO2018178077A1
(en)
|
2017-03-28 |
2018-10-04 |
Janssen Vaccines & Prevention B.V. |
Binding molecules that specifically bind to tau
|
SG11201908326YA
(en)
|
2017-03-28 |
2019-10-30 |
Genentech Inc |
Methods of treating neurodegenerative diseases
|
BR112019022906A2
(pt)
|
2017-05-02 |
2020-05-26 |
Prothena Biosciences Limited |
Anticorpos que reconhecem tau
|
JP2020529394A
(ja)
|
2017-06-16 |
2020-10-08 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
タウオパチーを治療するための組成物及び方法
|
MA50397A
(fr)
|
2017-10-16 |
2020-08-26 |
Eisai R&D Man Co Ltd |
Anticorps anti-tau et leurs utilisations
|
WO2019094595A2
(en)
|
2017-11-09 |
2019-05-16 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
AU2018380765A1
(en)
|
2017-12-04 |
2020-06-11 |
Janssen Vaccines & Prevention B.V. |
Binding molecules that specifically bind to tau
|
TW202003036A
(zh)
|
2018-03-23 |
2020-01-16 |
德商艾伯維德國有限及兩合公司 |
穩定水性抗-tau抗體調配物
|
EP3774887A2
(en)
|
2018-03-28 |
2021-02-17 |
Axon Neuroscience SE |
Antibody-based methods of detecting and treating alzheimer's disease
|
US20210230255A1
(en)
|
2018-04-27 |
2021-07-29 |
Fondazione Ebri Rita Levi-Montalcini |
Antibody directed against a tau-derived neurotoxic peptide and uses thereof
|
JOP20210098A1
(ar)
|
2018-11-08 |
2023-01-30 |
Prothena Biosciences Ltd |
أجسام مضادة تتعرف على تاو
|
CA3118818A1
(en)
|
2018-11-08 |
2020-05-14 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
WO2020106598A1
(en)
|
2018-11-19 |
2020-05-28 |
The Board Of Regents Of The University Of Texas System |
Tau peptide antigens and antibodies binding thereto for the treatment of tauopathies
|
EP3921343A4
(en)
|
2019-02-08 |
2022-12-14 |
Prothena Biosciences Limited |
ANTIBODIES FOR DETECTING TAU
|
EP3935083A4
(en)
|
2019-03-03 |
2022-11-30 |
Prothena Biosciences Limited |
ANTIBODIES RECOGNIZING TAU PROTEIN
|
WO2020193520A1
(en)
|
2019-03-25 |
2020-10-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of taupathy disorders by targeting new tau species
|
JP2022541539A
(ja)
|
2019-07-15 |
2022-09-26 |
アデル,インコーポレーテッド |
抗タウ抗体およびその使用
|